Creatine Supplementation During GLP-1a Therapy
GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
| Condition(s) | Sarcopenia |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass. |
| Who can participate | Inclusion Criteria: * Starting GLP-1 agonist therapy * 18 years of age or older Exclusion Criteria: * Positive answers to a screening questionnaire for physical activity safety (the Get Active Questionnaire) |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | University of Saskatchewan |
| Locations | Saskatoon, SK - Saskatchewan, Canada |
| Start date | 2026-05-25 |
| NCT ID | NCT07625202 |
| Official listing | https://clinicaltrials.gov/study/NCT07625202 |